Innovative Genomics Institute

IGI logoThe Innovative Genomics Institute is composed of diverse researchers with a powerful combined expertise. After the development of the CRISPR-Cas9 system for rewriting DNA, we saw the potential of applying this technology to solve some of humanity’s greatest problems. Our scientists conduct world-class research, driven by the real possibility to cure human disease, end hunger, and protect the environment.

In addition to our scientific efforts, the IGI is committed to advancing public understanding of genome engineering and providing resources for the broader community.

Director(s)
Co-Director
Brad Ringeisen (Executive Director)
Staff contact
Mailing address

Innovative Genomics Institute
2151 Berkeley Way
Berkeley, CA 94704

igi-info@berkeley.edu



In News

In 10 years, CRISPR Transformed Medicine. Can It Now Help Us Deal With Climate Change?

Coming from a long line of Iowa farmers, David Savage always thought he would do research to improve crops. That dream died in college, when it became clear that any genetic tweak to a crop would take at least a year to test; for some perennials and trees, it could take five to 10 years. Faced with such slow progress, he chose to study the proteins in photosynthetic bacteria instead. But the advent of CRISPR changed all that.

More infectious COVID variant detected in Berkeley

A more transmissible variant of the coronavirus, first detected in the United Kingdom, has shown up in two UC Berkeley students, as the state announced at least 133 new cases of the variant statewide. The appearance of the new variant, which appears to be about 50% more infectious than earlier variants, reinforces the need to take very seriously public health precautions to prevent spread: wear a mask when around other people, keep at least six feet apart and wash your hands frequently.